NCT03473860 (CCEMPCAD) is a clinical trial in Coronary Artery Disease, sponsored by Lu'an Municipal Hospital.

Who is sponsoring NCT03473860?

NCT03473860 is sponsored by Lu'an Municipal Hospital.

What condition does NCT03473860 study?

NCT03473860 studies Coronary Artery Disease.

Is NCT03473860 still recruiting?

NCT03473860 is currently status unknown. Last updated 22 March 2018.

Last reviewed 2018-03-22 · How we verify

NCT03473860: CCEMPCAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Change of CEM and the Prognosis of Coronary Artery Disease in Real Clinical Practice

Status unknown Last updated 22 March 2018

What this trial tests

trial in Coronary Artery Disease in 200 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Lu'an Municipal Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 April 2018
Primary completion	31 December 2021
Estimated completion	31 December 2021

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Lu'an Municipal Hospital

Who can join

Adults 45 to 70, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the change of total cholesterol content of erythrocyte membranes (CEM) in patients with coronary artery disease treated with secondary prevention drugs, and the correlation with the prognosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Lu'an Municipal Hospital trials

Trials by the same sponsor.

NCT03389529 — the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03473860 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lu'an Municipal Hospital
Last refreshed: 22 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03473860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing